Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials
To access this article, please choose from the options below
The study was supported in part by grants from the British Heart Foundation, London, England, and the Medical Research Council, London, England, and the European Union BIOMED Program (BMH4-98-3549), Brussels, Belgium.
PII: S0002-8703(05)00444-8
doi:10.1016/j.ahj.2005.04.025
© 2006 Mosby, Inc. All rights reserved.
